Navigation Links
AACR CEO Margaret Foti receives honorary M.D. from the University of San Pablo CEU
Date:6/17/2009

MADRID The University of San Pablo CEU, a major academic and research institution in Madrid, Spain, today presented Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research, with an honorary doctorate in medicine that recognizes her exceptional contributions to cancer research and leadership of the AACR, which have done so much to help those suffering from cancer.

"Margaret Foti exemplifies the social leadership and management needed worldwide for the prevention and treatment of cancer. Her tireless efforts on behalf of patients and scientists are now visible through the impressive resources that AACR is providing today to the international scientific community. Her years devoted to cancer research development and communication have inspired several generations of scientists to move forward to even greater heights, and we are proud to honor her with this degree," Fernando Vidal-Vanaclocha, M.D., professor at Basque Country University and pioneer of cancer metastasis research in Spain, said at today's ceremony.

Vidal-Vanaclocha presented Foti with the degree of M.D. "honoris causa." The degree is the first of its kind given in the University's 75-year history.

"Such awards in themselves have a special significance, but I personally believe that this is an honor that does justice to your exceptional work in the field of cancer research and to your leadership of an international organization that has done so much to advance our knowledge about cancer diseases and, therefore, to help those suffering from cancer," said Vidal-Vanaclocha.

Foti had been notified of the degree by the Governing Council of the University chaired by Alfredo Dagnino and was sworn in as M.D. "honoris causa" by the University Rector Alfonso Bullon de Mendoza.

"I am deeply humbled by this extraordinary recognition of my work, and I want to thank the university for seeing fit to honor me," said
'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Council for American Medical Innovation Applauds the Confirmation of Margaret Hamburg, M.D., to Lead U.S. Food and Drug Administration
2. Scientists discover how to improve immune response to cancer at Princess Margaret Hospital
3. USP applauds nomination of Dr. Margaret Hamburg as FDA Commissioner
4. GPhA Statement on Nomination of Dr. Margaret Hamburg as Commissioner and Dr. Joshua Sharfstein as Deputy Commissioner of FDA
5. Appointment of Margaret Hamburg to Lead FDA Lauded by Gov. Lowell Weicker, President of the Board of Trust for Americas Health
6. Margaret Laub Appointed to IntelliDOT Board of Directors
7. ABMS Appoints Margaret Jung As New COO
8. Margaret Dimond Named President and CEO of McLaren Medical Management Inc.
9. Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
10. Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital
11. Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...E,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharm...ecompanywillhosttwoinvestoreventsinDecember: ,,.../10:00a.m.ET ,, Principalinvestigatorswilldis...sedand/orrefractorymultiplemyeloma,asfeaturedatthe...ndExpositioninNewOrleans,LA.Theteleconferencewillb...
(Date:11/25/2009)...S,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInsti...eexecutiveleadershipfor2010. ,, ThenewBoardMemb...npublicpolicy,law,finance,governmenthealthprograms...ocomesfromawiderangeofpersonalbackgroundsincluding...ithHIVthemselves,andrepresentingmultipleagegroups....
(Date:11/25/2009)...discovery that grew out of a collaboration between...ffer hope to the nearly 10 million Americans who s...so known as hardening of the arteries, peripheral ...problem in which narrowed arteries reduce blood fl... flag for vascular disease, heart attack and strok...
(Date:11/25/2009)...lness could lead mothers to overlook needed care, ...thDay News) -- A mother,s depression can worsen he..., Their six-month study of 262 black mothers and t...d more depressive symptoms had more frequent asthm...epressive symptoms had less frequent asthma sympto...
(Date:11/25/2009)...mprovementShownforthe4thStraightYear ,, WASHI...ancerAlliance-Georgia(LCA-GA)issuedthe 4thAnnualRe...ogressbeingmadeagainstthislethaldiseaseinthestateo...,theonlynationalorganizationdedicatedexclusivelyto...skforlungcancer. ,, (Logo: http://www.newscom.c...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...raveled a chemical correspondent of the human geno...mises to be a harbinger of novel ways of diagnosin...tion of the human body. The project costing $7.5 m...s, 1,200 drugs and 3,500 food components, present ...
...mune systems should not eat raw// or undercooked s...Health Canada. “Eat veggies full of vitamins a...nd green beans help to keep us strong, energetic a...been blamed for bringing on sickness and even deat...
...ull of food, and are seen to be overeating, just t... Earlier, the government had stipulated that any...d get the obesity surgery done, free of cost. This...th conditions like diabetes and blood pressure are...
...chrane Library journal concludes //that the three ...alis, Levitra and Viagra appear to be safe and eff...uded in a family of medications called phosphodies...more likely than other men to deal with ED problem...
...edure to combat obesity in adolescents,// accordin...It is the first study to evaluate the lap band in ... patients on average lost about 50% of their exces... only approved by the Food and Drug Administration...
...a three-year $2.1 million grant to researchers// a... a new drug to treat bipolar disorder. The g... the brain and block the mania associated with the...sorder include so-called 'mood stabilizers' -- lit...
Other Medicine News:Health News:Raw (or) Undercooked Sprouts May Carry Harmful Bacteria 2Health News:ED Drugs - Safe and Effective for Diabetic Men 2Health News:Stomach Banding Surgery Effective for Adolescents 2Health News:Stomach Banding Surgery Effective for Adolescents 3Health News:UIC Researchers Receive $2.1 Million Grant 2
(Date:11/25/2009)...stCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevi...sruptivesurgicaltreatmentsforthespine,announcedtod...,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwil...Company,sproductsandwillincludecommentsfrommanagem...l-innumbersare1-877-407-4018fordomesticcallersand1...
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...elivery-USMarketTrends&Analysis http://www.re...-US-Market-Trends--Analysis.html ,, TheUSintra...erapeuticapplicationsfromthedeliveryofconventional...euticdrugs.Thefutureofthetechnologyhingesontotheef...
(Date:11/25/2009)...ewswire/-- ChemoCentryx,Inc.,announcedtodaythatPh...ProspectiveRandomizedOralTherapyEvaluationinCrohn,...swithmoderate-to-severeCrohn,sdiseasedemonstratedc...profile.Thestudydemonstratedevidenceofclinicaleffi...pointdecreaseintheCrohn,sDiseaseActivityIndex(CDAI...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Study finds colorectal cancer rates increasing worldwide 8769 1Study finds colorectal cancer rates increasing worldwide 8769 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 1Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 3Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 1Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 2
... for Presentation at 47th ICAAC on ..., Sept. 4 Ardea Biosciences,Inc. (Pink Sheets: AR...eted,Phase 1 single-ascending-dose, multiple-ascen...es of RDEA806, a novel HIV non-nucleoside reverse,...eers. The data from these Phase 1 clinical trials...
...ive analysis of,clinical trials known as a meta-an...tent was associated with significantly lower risks...mpared to the Taxus Stent out to 30,months after a...randomized,clinical trials and 8,695 patients, the...ed on the Journal of the American College of Cardi...
Other Medicine Technology:Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 2Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 4
Anterior Stromal Puncture Cannula, 25 g
Viscoelastic Cannula, 23 g. Angled
Anterior Chamber Needle, 21 g
Anterior Chamber Needle, 25 g. Angled
Medicine Products: